• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未来肝脏残存量作为肝癌肝切除术后术后发病率的预测指标 - 风险因素分析。

Future liver remnant function as a predictor of postoperative morbidity following liver resection for hepatocellular carcinoma - A risk factor analysis.

机构信息

Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany; Department of Gastroenterology and Hepatology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.

Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

出版信息

Surg Oncol. 2020 Jun;33:257-265. doi: 10.1016/j.suronc.2020.02.004. Epub 2020 Feb 8.

DOI:10.1016/j.suronc.2020.02.004
PMID:32561090
Abstract

BACKGROUND

Advances in anaesthesia and surgical technique have considerably reduced mortality in hepatocellular carcinoma (HCC) patients undergoing liver resection. However, extended resections in patients with liver cirrhosis still represent a challenge. The aim of this study was to investigate the predictive value of volume/function analysis for the prediction of morbidity in HCC patients following liver resection.

METHODS

Between 2001 and 2014, a total of 261 patients who underwent open hepatectomy for HCC were enrolled in this study. Future liver remnant volume (FLRV) and future liver remnant function (FLRF) based on LiMAx testing were obtained retrospectively. Uni- and multivariable analyses were performed to identify predictors for postoperative ascites, post-hepatectomy haemorrhage (PHH), and wound healing disorders (WHD) within the total cohort and in a subgroup of cirrhotic patients.

RESULTS

The most commonly observed complication was ascites (57.1%), followed by liver failure (25.3%), PHH (19.5%), and WHD (19.2%). FLRF was a major predictor of postoperative ascites (AUC 0.776; OR 0.987, p = 0.001), PHH (AUC 0.717; OR 0.984, p = 0.001), and WHD (AUC 0.660; OR 0.994, p = 0.032) in total cohort. Multivariable analysis of the cirrhosis subgroup showed FLRF to be an independent predictor of ascites (AUC 0.814; OR 0.989, p = 0.021), PHH (AUC 0.677; OR 0.991, p = 0.040), and WHD (AUC 0.615; OR 0.989, p = 0.033).

CONCLUSIONS

FLRF is a major predictor of postoperative ascites, haemorrhage, and wound healing disorders in cirrhotic and non-cirrhotic patients whereas FLRV failed to show significant correlations. Preoperative calculation of FLRF may augment surgical decision-making in high-risk patients and thereby improve perioperative outcome.

摘要

背景

麻醉和外科技术的进步显著降低了接受肝切除术的肝细胞癌(HCC)患者的死亡率。然而,在肝硬化患者中进行广泛切除术仍然是一个挑战。本研究旨在探讨体积/功能分析对预测 HCC 患者肝切除术后发病率的价值。

方法

2001 年至 2014 年间,共纳入 261 例接受开腹肝切除术的 HCC 患者。回顾性获得基于 LiMAx 检测的剩余肝体积(FLRV)和剩余肝功能(FLRF)。在总队列和肝硬化患者亚组中进行单变量和多变量分析,以确定术后腹水、肝切除术后出血(PHH)和伤口愈合障碍(WHD)的预测因素。

结果

最常见的并发症是腹水(57.1%),其次是肝功能衰竭(25.3%)、PHH(19.5%)和 WHD(19.2%)。FLRF 是术后腹水(AUC 0.776;OR 0.987,p=0.001)、PHH(AUC 0.717;OR 0.984,p=0.001)和 WHD(AUC 0.660;OR 0.994,p=0.032)的主要预测因素。肝硬化亚组的多变量分析显示,FLRF 是腹水(AUC 0.814;OR 0.989,p=0.021)、PHH(AUC 0.677;OR 0.991,p=0.040)和 WHD(AUC 0.615;OR 0.989,p=0.033)的独立预测因素。

结论

FLRF 是肝硬化和非肝硬化患者术后腹水、出血和伤口愈合障碍的主要预测因素,而 FLRV 则没有显示出显著的相关性。术前计算 FLRF 可能会增加高危患者的手术决策能力,从而改善围手术期结果。

相似文献

1
Future liver remnant function as a predictor of postoperative morbidity following liver resection for hepatocellular carcinoma - A risk factor analysis.未来肝脏残存量作为肝癌肝切除术后术后发病率的预测指标 - 风险因素分析。
Surg Oncol. 2020 Jun;33:257-265. doi: 10.1016/j.suronc.2020.02.004. Epub 2020 Feb 8.
2
The predictive value of future liver remnant function after liver resection for HCC in noncirrhotic and cirrhotic patients.肝切除术后非肝硬化和肝硬化患者剩余肝功能的预测价值。
HPB (Oxford). 2019 Jul;21(7):912-922. doi: 10.1016/j.hpb.2018.11.012. Epub 2019 Feb 4.
3
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.建立预测 Child-Pugh B 级肝硬化肝癌患者肝切除术后结局的列线图。
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
4
Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.肝细胞癌肝硬化患者肝切除术后难治性腹水:克服这一棘手并发症的危险因素分析
Anticancer Res. 2017 Mar;37(3):1381-1385. doi: 10.21873/anticanres.11459.
5
The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients.残余肝体积与体重比对肝硬化患者肝切除术后肝功能衰竭的预测价值。
J Surg Res. 2014 May 15;188(2):489-95. doi: 10.1016/j.jss.2014.01.023. Epub 2014 Jan 24.
6
Predictors of posthepatectomy ascites with or without previous portal vein embolization.有或无门静脉栓塞术前肝切除术后腹水的预测因素。
Dig Surg. 2012;29(6):468-74. doi: 10.1159/000345583. Epub 2013 Jan 7.
7
Cigarette smoking increases risk of early morbidity after hepatic resection in patients with hepatocellular carcinoma.吸烟会增加肝细胞癌患者肝切除术后早期发病的风险。
Eur J Surg Oncol. 2015 Apr;41(4):513-9. doi: 10.1016/j.ejso.2015.01.015. Epub 2015 Jan 26.
8
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.腹腔镜肝切除术:肝硬化和门静脉高压患者的优势是什么?系统评价和荟萃分析及个人经验。
J Laparoendosc Adv Surg Tech A. 2020 Oct;30(10):1054-1065. doi: 10.1089/lap.2020.0408. Epub 2020 Jul 20.
9
Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.腹腔镜手术治疗肝硬化患者肝肿瘤的益处。
J Laparoendosc Adv Surg Tech A. 2018 May;28(5):553-561. doi: 10.1089/lap.2017.0584. Epub 2018 Jan 19.
10
Perioperative outcomes after hepatectomy for hepatocellular carcinoma among patients with cirrhosis, fatty liver disease, and clinically normal livers.肝硬化、脂肪肝和临床正常肝脏患者行肝切除术后的围手术期结局。
Surg Oncol. 2024 Oct;56:102114. doi: 10.1016/j.suronc.2024.102114. Epub 2024 Jul 31.

引用本文的文献

1
Is conventional functional liver remnant volume higher than 40% still sufficient to prevent post-hepatectomy liver failure in jaundiced patients with hilar cholangiocarcinoma? A single-center experience in China.对于伴有黄疸的肝门部胆管癌患者,常规功能性剩余肝体积(>40%)是否仍足以预防肝切除术后肝功能衰竭?来自中国的单中心经验。
Cancer Med. 2024 Jul;13(13):e7342. doi: 10.1002/cam4.7342.
2
Extended Right Hepatectomy following Clearance of the Left Liver Lobe and Portal Vein Embolization for Curatively Intended Treatment of Extensive Bilobar Colorectal Liver Metastases: A Single-Center Case Series.左半肝及门静脉栓塞后扩大右半肝切除术治疗广泛双叶结直肠癌肝转移的疗效:单中心病例系列研究。
Curr Oncol. 2024 Feb 21;31(3):1145-1161. doi: 10.3390/curroncol31030085.
3
A new risk calculation model for complications of hepatectomy in adults over 75.一种针对75岁以上成年人肝切除术后并发症的新风险计算模型。
Perioper Med (Lond). 2024 Feb 26;13(1):10. doi: 10.1186/s13741-024-00366-y.
4
Establishment and Internal Validation of a Prognostic Score for Post-hepatectomy Liver Failure Based on Functional Liver Parameters Estimated via TC-99m GSA.基于通过TC-99m GSA估算的功能性肝脏参数建立肝切除术后肝衰竭预后评分并进行内部验证。
Cureus. 2023 Jul 22;15(7):e42297. doi: 10.7759/cureus.42297. eCollection 2023 Jul.
5
Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience.肝叶增生技术在治疗晚期肝泡型包虫病中的应用:单中心经验。
BMC Surg. 2022 Dec 6;22(1):415. doi: 10.1186/s12893-022-01864-w.
6
Liver Venous Deprivation (LVD) Versus Portal Vein Embolization (PVE) Alone Prior to Extended Hepatectomy: A Matched Pair Analysis.扩大肝切除术前肝静脉阻断(LVD)与单纯门静脉栓塞(PVE)的配对分析
Cardiovasc Intervent Radiol. 2022 Jul;45(7):950-957. doi: 10.1007/s00270-022-03107-0. Epub 2022 Mar 21.
7
Treatment of Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma: liver resection versus TACE and beyond.巴塞罗那临床肝癌C期肝细胞癌的治疗:肝切除术与经动脉化疗栓塞术及其他治疗方法的比较
Ann Transl Med. 2020 Oct;8(19):1209. doi: 10.21037/atm-20-4903.